Evedientes, Esterlita M.
HRN: 12-09-40 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/21/2023
CEFTRIAXONE 1G (VIAL)
12/21/2023
12/28/2023
IV
2g
Q24
CAP MR
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes